The earnings call highlighted strong operational cash flow, significant account receivable reduction, and expansion in key business areas such as medical transport and payer-provider verticals. However, there were notable challenges in overall revenue decline and adjusted EBITDA losses due to the wind-down of migrant-related programs.

Company Guidance -

Q3 2025

During the DocGo Second Quarter Earnings Conference Call for Fiscal Year 2025, the company provided guidance and highlighted several key metrics. DocGo reported a notable increase in cash flow from operations, totaling over $30 million, alongside a reduction in migrant-related accounts receivable from approximately $120 million last quarter to roughly $54 million by the end of Q2. The total cash, including restricted cash and investments, rose to $128.7 million, up $25.6 million from the previous quarter. The company achieved significant operational milestones, including completing more than 176,000 medical transports, over 6,000 gap closure and transitional care management visits, and more than 28,000 mobile phlebotomy visits. Additionally, the payer and provider vertical saw an increase in assigned lives to 1.2 million, up from 900,000 the previous quarter, and they anticipate ending the year with more than 31,000 care gap visits, with plans to increase this to over 54,000 by the end of 2026. Despite a decline in total revenue to $80.4 million from $164.9 million the previous year, mainly due to a decrease in government vertical revenues, DocGo remains optimistic about achieving positive adjusted EBITDA in the back half of 2026, with projected quarterly revenues ranging from $80 million to $85 million.

Strong Cash Flow and Balance Sheet Improvements

DocGo reported a strong cash flow from operations totaling more than $30 million for Q2 2025, with a total cash increase of $25.6 million from the last quarter, ending Q2 with $128.7 million.

Significant Reduction in Accounts Receivable

Accounts receivable from migrant-related programs decreased from $120 million to approximately $54 million by the end of Q2 2025.

Operational Achievements in Medical Transport

DocGo completed more than 176,000 medical transports in Q2 and launched a major new customer in New York expected to drive record volumes in the second half of the year.

Expansion in Payer and Provider Vertical

The care gap closure program expanded to 1.2 million assigned lives, up from 900,000 in the previous quarter, and patient conversions increased by 50% in Q2 relative to the previous quarter.

Technology and AI Integration

A text-based AI agent was launched to automate appointment reminders and rescheduling, saving approximately 10% of live operators' time.

Stock Buyback Program

DocGo repurchased 2.5 million shares for approximately $5.1 million during Q2 2025.

DocGo (DCGO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DCGO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	-0.12 / -	0.05	―	―	―
Aug 07, 2025	2025 (Q2)	-0.10 / -0.11	0.06	-283.33% (-0.17)	―
May 08, 2025	2025 (Q1)	-0.03 / -0.09	0.1	-190.00% (-0.19)	―
Feb 27, 2025	2024 (Q4)	0.04 / -0.03	0.075	-140.00% (-0.10)	―
Nov 07, 2024	2024 (Q3)	0.04 / 0.05	0.05	0.00% (0.00)	―
Aug 07, 2024	2024 (Q2)	0.06 / 0.06	-0.02	400.00% (+0.08)	―
May 08, 2024	2024 (Q1)	0.08 / 0.10	-0.03	433.33% (+0.13)	―
Feb 28, 2024	2023 (Q4)	0.10 / 0.07	0.11	-31.82% (-0.04)	―
Nov 06, 2023	2023 (Q3)	0.06 / 0.05	0.03	66.67% (+0.02)	―
Aug 07, 2023	2023 (Q2)	0.03 / -0.02	0.11	-118.18% (-0.13)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

DCGO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$1.39	$1.57	+12.95%
May 08, 2025	$2.33	$1.40	-39.91%
Feb 27, 2025	$3.92	$3.09	-21.17%
Nov 07, 2024	$3.61	$4.00	+10.80%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does DocGo (DCGO) report earnings?

DocGo (DCGO) is schdueled to report earning on Nov 10, 2025, After Close (Confirmed).

What is DocGo (DCGO) earnings time?

DocGo (DCGO) earnings time is at Nov 10, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is DCGO EPS forecast?

DCGO EPS forecast for the fiscal quarter 2025 (Q3) is -0.12.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing